Inicio › Enfermedad de Crohn › South Carolina
Ensayos clínicos de Enfermedad de Crohn en South Carolina
12 estudios sobre Enfermedad de Crohn buscan participantes en South Carolina.
Ciudades en South Carolina
Texto oficial del estudio (inglés)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates, PA, Greenville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06233461A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Johns Hopkins University Gastroenterology and Hepatology-Site Number: 8400116, Columbia
- Biocentric Health Research Center-Site Number: 8400089, Columbia
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Palmetto Gastroenterology Clinical Research, Summerville
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06226883A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Medical University of South Carolina (MUSC), Charleston
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 15 ene 2026 · NCT06257706De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.